Top Markets
#1 Siacoin Siacoin +33.03%
#2 Official Trump Official Trump +30.32%
#3 Nockchain Nockchain +21.49%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +19.40%
#5 Melania Meme Melania Meme +18.94%
#6 EXOD EXOD +18.93%
#7 MowCat MowCat +18.54%
#8 Mubarak Mubarak +16.90%
#9 Pump.fun Pump.fun +15.47%
#10 Unit Pump Unit Pump +15.47%
Coin of the day
Siacoin Siacoin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Harpoon Therapeutics, Inc. Harpoon Therapeutics, Inc.

Harpoon Therapeutics, Inc.

HARP
Classement en actions #23352
Harpoon Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Harpoon Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to immunotherapy, focused on engineering a novel class of T cell activators. These therapies are designed to leverage the body's own immune system to fight cancer and other diseases in patients across the United States. The company's innovative Tri-specific T cell activating construct (TriTAC) platform forms the basis of its development pipeline. This includes HPN328, currently undergoing Phase I/II clinical trials for small cell lung cancer and tumors that express Delta-like canonical Notch ligand 3; HPN217, also in Phase I/II trials for the treatment of multiple myeloma; and HPN536, which is in Phase I/IIa clinical evaluation for ovarian and pancreatic cancers, alongside other mesothelin-expressing tumors. Furthermore, Harpoon has a preclinical asset, HPN601, aimed at various solid tumor indications. The company has also established a discovery collaboration and licensing agreement with AbbVie Biotechnology Ltd. to develop and market products combining its unique TriTAC technology with soluble T cell receptors. Founded in 2015, Harpoon Therapeutics, Inc. is headquartered in South San Francisco, California.
Prix de l'action
$23.01
Dernière synchronisation: 2024-03-11
Capitalisation boursière
$74.80M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Harpoon Therapeutics, Inc. (HARP)

Catégorie

Healthcare
Historique du prix de l'action pour Harpoon Therapeutics, Inc. (HARP)
Prix de clôture le plus élevé : $22.98 le 2024-03-01

Prix de clôture le plus bas : $146.51 le 2019-02-01
Historique du prix de l'action de Harpoon Therapeutics, Inc. de 2019 à 2026
Performance annuelle du prix de l'action
Année Performance
2024 118.66%
2023 37.41%
2022 -88.70%
2021 -54.80%
2020 -14.80%
2019 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH